part i item 1 . business . merck & co. , inc . ( 201cmerck 201d or the 201ccompany 201d ) is a global health care company that delivers innovative health solutions through its prescription medicines , vaccines , biologic therapies , animal health , and consumer care products , which it markets directly and through its joint ventures . the company 2019s operations are principally managed on a products basis and are comprised of four operating segments , which are the pharmaceutical , animal health , consumer care and alliances segments , and one reportable segment , which is the pharmaceutical segment . the pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures . human health pharmaceutical products consist of therapeutic and preventive agents , generally sold by prescription , for the treatment of human disorders . the company sells these human health pharmaceutical products primarily to drug wholesalers and retailers , hospitals , government agencies and managed health care providers such as health maintenance organizations , pharmacy benefit managers and other institutions . vaccine products consist of preventive pediatric , adolescent and adult vaccines , primarily administered at physician offices . the company sells these human health vaccines primarily to physicians , wholesalers , physician distributors and government entities . the company also has animal health operations that discover , develop , manufacture and market animal health products , including vaccines , which the company sells to veterinarians , distributors and animal producers . additionally , the company has consumer care operations that develop , manufacture and market over-the- counter , foot care and sun care products , which are sold through wholesale and retail drug , food chain and mass merchandiser outlets , as well as club stores and specialty channels . the company was incorporated in new jersey in for financial information and other information about the company 2019s segments , see item 7 . 201cmanagement 2019s discussion and analysis of financial condition and results of operations 201d and item 8 . 201cfinancial statements and supplementary data 201d below . all product or service marks appearing in type form different from that of the surrounding text are trademarks or service marks owned , licensed to , promoted or distributed by merck , its subsidiaries or affiliates , except as noted . all other trademarks or services marks are those of their respective owners . product sales sales of the company 2019s top pharmaceutical products , as well as total sales of animal health and consumer care products , were as follows: .

Table: ( $ in millions ) 2013 2012 2011 total sales $ 44033 $ 47267 $ 48047 pharmaceutical 37437 40601 41289 januvia 4004 4086 3324 zetia 2658 2567 2428 remicade 2271 2076 2667 gardasil 1831 1631 1209 janumet 1829 1659 1363 isentress 1643 1515 1359 vytorin 1643 1747 1882 nasonex 1335 1268 1286 proquad/m-m-rii/varivax 1306 1273 1202 singulair 1196 3853 5479 animal health 3362 3399 3253 consumer care 1894 1952 1840 other revenues ( 1 ) 1340 1315 1665

other revenues ( 1 ) 1340 1315 1665 ( 1 ) other revenues are primarily comprised of alliance revenue , miscellaneous corporate revenues and third-party manufacturing sales . on october 1 , 2013 , the company divested a substantial portion of its third-party manufacturing sales . table of contents .

Question: what is the growth rate in total sales in 2012?
Answer: -1.6%
Calculation: divide(subtract(47267, 48047), 48047)